Two expert radiologists using the ONCO-RADS system to rate MRI scans agreed on the cancer risk level in nearly all cases — showing the system is consistent and not just based on personal opinion.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether ONCO-RADS has consistently high interobserver reliability across diverse institutions, scanner types, and reader experience levels.
A systematic review and meta-analysis of all studies reporting kappa or ICC values for ONCO-RADS inter-rater reliability across ≥15 studies, stratified by reader experience, MRI field strength, and training level.
Whether training radiologists in ONCO-RADS improves diagnostic consistency compared to untrained readers.
A multicenter RCT of 100 radiologists randomized to ONCO-RADS training vs. no training, interpreting 50 standardized WB-MRI cases, with primary outcome: inter-rater agreement (kappa) on ONCO-RADS categories.
Whether ONCO-RADS reliability remains high over time and across multiple readers in routine clinical practice.
A prospective cohort study of 50 radiologists interpreting 500 consecutive WB-MRI cases over 12 months, with monthly re-evaluation of inter-rater agreement using kappa statistics.
Whether cases with low inter-rater agreement are more likely to be misclassified or lead to inappropriate follow-up.
A case-control study of 200 WB-MRI cases with low inter-rater agreement (kappa <0.6) vs. 400 with high agreement, comparing rates of misclassification and subsequent diagnostic errors.
The level of agreement among multiple radiologists using ONCO-RADS in a single institution.
A cross-sectional study of 10 radiologists independently classifying 100 consecutive WB-MRI cases using ONCO-RADS, with kappa calculated for each pair and overall agreement.